

Issue Date | Title | Author(s) | Type | Мp-cat. |
---|---|---|---|---|
2023 | Molecular Biomarkers in Perthes Disease: A Review![]() | Spasovski, Vesna ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2023 | Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis![]() | Kostić Perić, Jelena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2021 | Case Report: Successful Therapy of Spontaneously Occurring Canine Degenerative Lumbosacral Stenosis Using Autologous Adipose Tissue-Derived Mesenchymal Stem Cells | Mrkovacki, Janko; Srzentić Dražilov, Sanja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21aM21a |
2021 | Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond![]() | Seman, Stefan; Srzentić Dražilov, Sanja ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2020 | Complex transcriptional regulation of the BCL2L12 gene: Novel, active promoter in K562 cells | Nikčević, Gordana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2020 | Metabolic Syndrome in Inflammatory Bowel Disease: Association with Genetic Markers of Obesity and Inflammation![]() | Dragašević, Sanja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2020 | Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy![]() | Stanković, Biljana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2019 | HYPERPHENYLALANINEMIA: FROM COMPLEX GENETICS TO COMPLEX PHENOTYPES![]() | Kristel Klaassen ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2018 | Importance of TLR9-IL23-1L17 axis in inflammatory bowel disease development: Gene expression profiling study![]() | Dragašević, Sanja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2018 | The use of canine mesenchymal stem cells for the autologous treatment of osteoarthritis | Srzentić Dražilov, Sanja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2017 | New PAH gene promoter KLF1 and 3'-region C/EBPalpha motifs influence transcription in vitro![]() | Klaassen, Kristel ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2015 | Predictive genetic markers of coagulation, inflammation and apoptosis in Perthes disease-Serbian experience | Srzentić Dražilov, Sanja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2015 | Efficient expression of human IL-10 following the optimization of transient transfection of canine adipose tissue-derived mesenchymal stem cells | Đokić, Jelena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2015 | Molecular characterization of mutations in Serbian patients with glycogen storage diseases.![]() | Skakic, Anita ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2014 | Association of gene variants in TLR4 and IL-6 genes with perthes disease | Srzentić, Sanja ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2013 | The influence of novel transcriptional regulatory element in intron 14 on the expression of Janus kinase 2 gene in myeloproliferative neoplasms![]() | Spasovski, Vesna ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2013 | -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis | Jančić, Ivan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2013 | Promoter polymorphisms of the TNF a (-308 G/A) and IL-6 (-174G/C) genes predict therapeutic response to etanercept![]() | Ivan, Jančić ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2012 | Terapijski odgovor na etanercept u reumatoidnom artritisu zavisi od -174G/C polimorfizma u genu za IL-6![]() | Arsenović-Ranin, Nevena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2012 | Expression of bcl2l12 gene in chronic lymphocytic leukemia: association with clinical and molecular prognostic markers | Karan-Đurašević, Teodora ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |